Discover 1,378 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
St. Louis currently offers medical research opportunities for a variety of conditions, including cancer, heart disease, prurigo nodularis, and pain management. The city's leading institutions are actively recruiting participants, offering opportunities for healthy volunteers in paid studies, as well as those seeking trials for specific health conditions, providing access to innovative treatments and advanced medical care.
Filter
2
Filter results
Results: 1,378
Active & Responsive
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Saint Louis MO, Sunset Hills MO, O'Fallon IL, Alton IL,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05929768
Phase3, Recruiting
Active & Responsive
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
for
Solid Tumor
Location: St Louis MO, Nashville TN, Detroit MI, Oklahoma City OK,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06384807
Phase1, Phase2, Recruiting
Active & Responsive
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
for
Chronic Kidney Diseases, End Stage Renal Disease,
Location: St Louis MO, Columbia MO, Memphis TN, Lexington KY,
Location: St Louis MO, Peoria IL, Iowa City IA, Indianapolis IN,
Sponsor: Chris Goss
Sex: All
Age: 6+
Code: NCT05548283
Recruiting
Active & Responsive
Gastroschisis Outcomes of Delivery (GOOD) Study
for
Gastroschisis
Location: St Louis MO, Peoria IL, Indianapolis IN, Kansas City MO,
Sponsor: Medical College of Wisconsin
Sex: Female
Age: 18+
Code: NCT02774746
Recruiting
Active & Responsive
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
for
Alagille Syndrome
Location: St Louis MO, Kansas City MO, Memphis TN, Dallas TX,
Sponsor: Ipsen
Sex: All
Age: 0+
Code: NCT06850038
Recruiting
Active & Responsive
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
for
Alpha1-Antitrypsin Deficiency
Location: St Louis MO, Iowa City IA, Indianapolis IN,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT05677971
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: St Louis MO, Columbia MO, Clarksville TN,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase3, Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: St Louis MO, Iowa City IA, Westwood KS, Louisville KY,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase2, Phase3, Recruiting
Active & Responsive
Neuroimaging of Parkinson's
for
Parkinsons Disease (PD)
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 40+
Code: NCT07024875
Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: St Louis MO, Creve Coeur MO, O'Fallon IL, Shiloh IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase2, Recruiting
Active & Responsive
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Location: St Louis MO, Creve Coeur MO, City of Saint Peters MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03816345
Phase1, Recruiting
Active & Responsive
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer,
Location: St Louis MO, Nashville TN, Chicago IL, Grand Rapids MI,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07361562
Phase1, Recruiting
Active & Responsive
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
for
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL),
Location: St Louis MO, Chicago IL, Cincinnatti OH, Omaha NE,
Sponsor: Umoja Biopharma
Sex: All
Age: 18+
Code: NCT06528301
Phase1, Recruiting
Active & Responsive
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
for
Urothelial Carcinoma
Location: St Louis MO, Indianapolis IN, Chicago IL, Cleveland OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05562830
Phase1, Phase2, Recruiting
Active & Responsive
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII